Aeluma Inc.
10/22/2026 | Press release | Distributed by Public on 10/22/2026 11:00
Material Event (Form 8-K)
Item 8.01 Other Events.
As previously reported in our Annual Report on Form 10-K for the fiscal year ended June 30, 2026, on May 23, 2026, Jonathan Klamkin, our President, Chief Executive Officer, and Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that provided for the sale of up to 300,000 shares of our common stock.
On October 21, 2026, Dr. Klamkin terminated the 10b5-1 trading arrangement.
Aeluma Inc. published this content on October 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 22, 2026 at 17:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]